2 days (range 10 d prior to 7 d after). The main clinical presentation of RTI was influenza-like illness (n = 76; 67.3%). Among the 99 microbiologically evaluated patients, a pathogen was found by polymerase chain reaction (PCR) or throat culture in 65 patients (65.6%). The main etiological agents were influenza A(H1N1) 2009 (18%),

click here influenza viruses (14%), and rhinovirus (20%). A univariate analysis was unable to show variables associated with influenza A(H1N1) 2009, whereas rhinorrhea was associated with viruses other than influenza (p = 0.04). Conclusion. Despite the A(H1N1) 2009 influenza pandemic, rhinovirus and other influenza viruses were also frequent causes of RTI in overseas travelers. Real-time reverse

transcription-PCR and nasopharyngeal swab cultures are useful diagnostic tools for evaluating travelers with RTI. Respiratory tract infections (RTIs) are a significant cause of health problems, accounting for 7%–11% of consultations in returning travelers.1,2 The prevalence of RTI is invariably higher in travelers presenting with fever, as RTIs account www.selleckchem.com/products/Adrucil(Fluorouracil).html for 14%–24% of the etiologies of fever.2–4 However, the spectrum of microbial agents causing RTI in travelers has been investigated in only limited circumstances or selected populations. Influenza is recognized as a significant cause of fever and RTI infections in travelers. An Australian study found that influenza was responsible for 5% of the 56 RTIs diagnosed in 232 returning travelers and immigrants/refugees presenting with fever.3 Seroconversion for influenza virus was confirmed in 12% of 211 febrile Swiss travelers compared with 2.8% for all Swiss travelers surveyed; the incidence was estimated to be around one influenza-associated event per 100 person-months abroad.5 However, a high number of RTIs remain unexplained, mostly owing to a lack of evaluation and the rapid, spontaneous recovery of patients. At the end of April 2009, a new influenza

virus A(H1N1) outbreak was identified in Mexico and spread rapidly to North America then to Europe and the rest of the world through international travelers.6,7 The rapid progression of the disease led the WHO to declare a phase 6 pandemic on June 11, 2009.8 During Rebamipide the first months of the outbreak in France, travelers were given particular attention and those with presumed signs of influenza were advised to immediately consult dedicated infectious disease units until July 17, 2009.9 This gave us an opportunity to evaluate the microbiological etiologies of RTI in travelers during the first months of the new Influenza virus A(H1N1) 2009 outbreak (April–July 2009). Although cell culture is the “gold standard” for the detection of respiratory viruses, it is impractical for general use in travelers, so, we evaluated the use of a multiplex polymerase chain reaction (PCR) assay in this setting.